0000315066-24-002996.txt : 20241206
0000315066-24-002996.hdr.sgml : 20241206
20241206115050
ACCESSION NUMBER: 0000315066-24-002996
CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20241206
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncology Institute, Inc.
CENTRAL INDEX KEY: 0001799191
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 843562323
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-91458
FILM NUMBER: 241531287
BUSINESS ADDRESS:
STREET 1: 18000 STUDEBAKER RD
STREET 2: SUITE 800
CITY: CERRITOS
STATE: CA
ZIP: 90703
BUSINESS PHONE: 562-735-3226
MAIL ADDRESS:
STREET 1: 18000 STUDEBAKER RD
STREET 2: SUITE 800
CITY: CERRITOS
STATE: CA
ZIP: 90703
FORMER COMPANY:
FORMER CONFORMED NAME: DFP HEALTHCARE ACQUISITIONS CORP.
DATE OF NAME CHANGE: 20200108
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: FMR LLC
CENTRAL INDEX KEY: 0000315066
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000]
ORGANIZATION NAME:
IRS NUMBER: 043532603
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G/A
BUSINESS ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6175706339
MAIL ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: FMR CORP
DATE OF NAME CHANGE: 19920717
SCHEDULE 13G/A
1
primary_doc.xml
SCHEDULE 13G/A
0000315066-22-000772
0000315066
XXXXXXXX
LIVE
3
COMMON STOCK
11/29/2024
0001799191
ONCOLOGY INSTITUTE INC/THE
68236X100
18000 STUDEBAKER RD
SUITE 800
CERRITOS
CA
90703
Rule 13d-1(b)
FMR LLC
DE
0.00
0.00
0.00
0.00
0.00
0.0
HC
Abigail P. Johnson
X1
0.00
0.00
0.00
0.00
0.00
0.0
IN
ONCOLOGY INSTITUTE INC/THE
18000 STUDEBAKER RD,SUITE 800,CERRITOS,CA,USA,90703
FMR LLC
245 Summer Street, Boston, Massachusetts 02210
Not applicable
N
HC
0.00
0.0
Please see the responses to Items 5 and 6 on the cover page.
0.00
0.00
0.00
N
Y
Y
N
See attached Exhibit 99.
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11240.14.,A.-11.
Please see Exhibit 99 for 13d-1(k) (1) agreement.
FMR LLC
Stephanie J. Brown
Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
12/05/2024
Abigail P. Johnson
Stephanie J. Brown
Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
12/05/2024
* This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003.** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
EX-99
2
exhibit99.txt
Exhibit 99
Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer
of FMR LLC.
Members of the Johnson family, including Abigail P. Johnson, are the
predominant owners, directly or through trusts, of Series B voting common
shares of FMR LLC, representing 49% of the voting power of FMR LLC. The
Johnson family group and all other Series B shareholders have entered into a
shareholders' voting agreement under which all Series B voting common shares
will be voted in accordance with the majority vote of Series B voting common
shares. Accordingly, through their ownership of voting common shares and the
execution of the shareholders' voting agreement, members of the Johnson family
may be deemed, under the Investment Company Act of 1940, to form a controlling
group with respect to FMR LLC.
This filing reflects the securities beneficially owned, or that may be deemed
to be beneficially owned, by FMR LLC, certain of its subsidiaries and
affiliates, and other companies (collectively, the "FMR Reporters"). This
filing does not reflect securities, if any, beneficially owned by certain
other companies whose beneficial ownership of securities is disaggregated from
that of the FMR Reporters in accordance with Securities and Exchange
Commission Release No. 34-39538 (January 12, 1998).
RULE 13d-1(k)(1) AGREEMENT
The undersigned persons, on December 5, 2024, agree and consent to the joint
filing on their behalf of this Schedule 13G in connection with their
beneficial ownership of the COMMON STOCK of ONCOLOGY INSTITUTE INC/THE at
November 29, 2024.
FMR LLC
By /s/ Stephanie J. Brown
Stephanie J. Brown
Duly authorized under Power of Attorney effective as of January 3, 2023, by
and on behalf of FMR LLC and its direct and indirect subsidiaries*
Abigail P. Johnson
By /s/ Stephanie J. Brown
Stephanie J. Brown
Duly authorized under Power of Attorney effective as of January 26, 2023, by
and on behalf of Abigail P. Johnson**
* This power of attorney is incorporated herein by reference to Exhibit 24 to
the Schedule 13G filed by FMR LLC on January 10, 2023, accession number:
0000315066-23-000003.
** This power of attorney is incorporated herein by reference to Exhibit 24 to
the Schedule 13G filed by FMR LLC on January 31, 2023, accession number:
0000315066-23-000038.